Drugs that contain Atazanavir Sulfate; Cobicistat

1. Drug name - EVOTAZ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8148374 BRISTOL-MYERS SQUIBB Modulators of pharmacokinetic properties of therapeutics
Sep, 2029

(6 years from now)

CN101796040A BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2013

(9 years ago)

CN101679325A BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570A BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101490023B BRISTOL-MYERS SQUIBB Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033A BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN103435570B BRISTOL-MYERS SQUIBB Pharmacokinetics Character Regulator Of Therapeutic Agent
Jul, 2027

(4 years from now)

CN103275033B BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

CN101679325B BRISTOL-MYERS SQUIBB Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent
Jul, 2027

(4 years from now)

CN101490023A BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

IN332719B BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

IN200810487P1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487165A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP3112355A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2487165B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506A2 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2049506B9 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2027

(4 years from now)

EP2118082B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487161A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2118082A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487162A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487166B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP3150586A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Feb, 2028

(5 years from now)

EP2487163A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2487163B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Mar, 2028

(5 years from now)

EP2170851B1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

EP2170851A1 BRISTOL-MYERS SQUIBB Modulators Of Pharmacokinetic Properties Of Therapeutics
Jul, 2028

(5 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10039718 BRISTOL-MYERS SQUIBB Use of solid carrier particles to improve the processability of a pharmaceutical agent Oct, 2032

(10 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 300MG BASE;150MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.